The pathogen Mycobacterium avium complex (MAC) is the most common cause of
nontuberculous mycobacterial pulmonary disease worldwide. The decision to initiate long …

Abstract Rationale 5-methoxy-N, N-dimethyltryptamine is a psychotropic substance found in
various plant and animal species and is synthetically produced. 5-methoxy-N, N …

Background In multidrug regimens, including an intravenous aminoglycoside (eg amikacin
[AMK]) is recommended for difficult-to-treat non-tuberculous mycobacterial (NTM) lung …

Background Nontuberculous mycobacterial (NTM) lung disease is one of a growing number
of chronic health problems that is difficult to cure in aging societies. While it is important to be …

Assessing progression of disease or response to treatment remains a major challenge in the
clinical management of nontuberculous mycobacterial (NTM) infections of the lungs. Serial …

Background The global prevalence and incidence of nontuberculous mycobacteria (NTM)
infection are increasing. However, the prevalence of NTM infection-associated comorbidities …

Abstract Background Treatment of Mycobacterium avium complex pulmonary disease (MAC-
PD) involves prolonged courses of multiple antibiotics that are variably tolerated and …

Background. Pulmonary resection along with multiple antimicrobial therapy has produced
favorable outcomes at a few centers. However, little is known regarding the risk factors for …

Mycobacteria remain an important problem worldwide, especially drug resistant human
pathogens. Novel therapeutics are urgently needed to tackle both drug-resistant …

Background and objective No reports exist regarding skeletal muscle involvement in
patients with Mycobacterium avium complex lung disease (MAC-LD). The cross-sectional …